Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 204,589 | 84,018 | 91,564 | 113,941 | 93,542 |
| Marketable Securities | 437,476 | 470,500 | 504,867 | 542,834 | 616,813 |
| Other current assets | 4,562 | 5,974 | 3,744 | 7,577 | 7,352 |
| TOTAL | $658,462 | $578,279 | $624,014 | $680,392 | $739,659 |
| Non-Current Assets | |||||
| PPE Net | 1,222 | 1,726 | 2,359 | 3,461 | 5,148 |
| Intangibles | 0 | 0 | 0 | 0 | 2,300 |
| Other Non-Current Assets | 39,929 | 41,326 | 43,627 | 44,988 | 52,255 |
| TOTAL | $41,151 | $43,052 | $45,986 | $48,449 | $59,703 |
| Total Assets | $699,613 | $621,331 | $670,000 | $728,841 | $799,362 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,104 | 7,705 | 2,752 | 5,176 | 8,450 |
| Accrued Expenses | 20,912 | 13,645 | 25,132 | 23,215 | 20,990 |
| Other current liabilities | 847 | 463 | 1,078 | 609 | 1,682 |
| TOTAL | $29,751 | $25,578 | $32,605 | $32,525 | $37,052 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 27,679 | 28,693 | 29,686 | 30,658 | 41,229 |
| TOTAL | $27,679 | $28,693 | $29,686 | $30,658 | $41,229 |
| Total Liabilities | $57,430 | $54,271 | $62,291 | $63,183 | $78,281 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 191,586 | 178,726 | 173,322 | 172,411 | 171,445 |
| Common Shares | 182 | 168 | 168 | 168 | 168 |
| Retained earnings | -2,088,060 | -2,014,769 | -1,959,879 | -1,885,730 | -1,815,355 |
| Other shareholders' equity | -172 | 733 | 493 | -163 | 38 |
| TOTAL | $642,183 | $567,060 | $607,709 | $665,658 | $721,081 |
| Total Liabilities And Equity | $699,613 | $621,331 | $670,000 | $728,841 | $799,362 |